Back to AMRXView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Uncomplicated Urinary Tract Infections
View Full LandscapeDrug Information
Target Indication
Uncomplicated Urinary Tract Infections
Clinical Trial
NCT01650051Last updated: 1/12/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Testosterone Topical Gel, 1.62% Metered PumpPhase 3
Primary Hypogonadism
Estradiol Vaginal Tablets 10 mcgPhase 3
Atrophic Vaginitis Due to Menopause
Asenapine Sublingual Tablets 10 mgPhase 3
Schizophrenia
Imatinib Mesylate Tablets, 400 mgPhase 3
Chronic Myeloid Leukemia
Phenazopyridine HydrochloridePhase 3
Pain
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts